The company's financial stability is under pressure, evidenced by a current ratio that has deteriorated to 0.84 as of 2026Q4.
| Metric | Mar'26 | Mar'25 | Mar'24 | Mar'23 | Mar'22 | Mar'21 | Mar'20 | Mar'19 | Mar'18 | Mar'17 | Mar'16 | Mar'15 | Mar'14 | Mar'13 | Mar'12 | Mar'11 | Mar'10 | Mar'09 | Mar'08 | Mar'07 | Mar'06 | Mar'05 | Mar'04 | Mar'03 | Mar'02 | Mar'01 | Mar'00 |
|---|
| Total Current Assets | 43.56M | 78.87M | 93.65M | 130.43M | 151M | 161.19M | 129.02M | 126.43M | 105.23M | 81.78M | 67.63M | 80.4M | 74.21M | 70.19M | 87.61M | 89.6M | 86.5M | 61.63M | 45.22M | 57.97M | 39.95M | 25.87M | 15.82M | 6.38M | 3.48M | 1.22M | 2.9M |
| Cash & Short-Term Investments | 21.41M | 54.72M | 55.3M | 104.09M | 111.08M | 118.72M | 103.76M | 100.53M | 77.94M | 58.73M | 37.64M | 51.2M | 33.84M | 33.65M | 57.15M | 59.78M | 53.14M | 30.13M | 25.05M | 39.44M | 23.22M | 12.68M | 3.28M | 984.17K | 737.28K | 408.7K | 311.85K |
| Cash Only | 21.41M | 54.72M | 55.3M | 104.09M | 111.08M | 118.72M | 103.76M | 100.53M | 77.94M | 58.73M | 37.64M | 35.61M | 18.3M | 18.16M | 46.8M | 49.66M | 53.14M | 30.13M | 20.27M | 316.47K | 23.22M | 12.68M | 3.28M | 984.17K | 737.28K | 408.7K | 311.85K |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 15.59M | 15.54M | 15.49M | 10.35M | 10.12M | 0 | 0 | 4.78M | 39.13M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 1.91M | 2.32M | 3.28M | 1.74M | 1.91M | 2.59M | 3.84M | 2.54M | 2.29M | 1.81M | 1.72M | 1.93M | 1.76M | 1.44M | 1.57M | 1.99M | 2.1M | 2.88M | 1.58M | 1.37M | 1.16M | 1.8M | 1.13M | 651.88K | 291.51K | 162.47K | 187.87K |
| Days Sales Outstanding | 3.89 | 3.73 | 4.37 | 2.48 | 2.55 | 3.11 | 4.94 | 3.27 | 3.06 | 2.65 | 2.68 | 3.07 | 2.75 | 2.31 | 2.41 | 3.13 | 3.21 | 4.79 | 3.05 | 3.08 | 3.07 | 6.05 | 4.4 | 4.33 | 3.32 | 5.93 | 4.67 |
| Inventory | 13.61M | 16.2M | 28.56M | 19.02M | 32.45M | 34.42M | 17.88M | 21.37M | 23.34M | 20.23M | 25.59M | 25.07M | 35.73M | 31.6M | 26.22M | 25.14M | 29.06M | 26.78M | 17.91M | 16.09M | 15M | 11.18M | 11.18M | 4.27M | 2.31M | 631.39K | 1.75M |
| Days Inventory Outstanding | 38.56 | 37.47 | 53.07 | 37.36 | 59.8 | 57.3 | 32.18 | 41.47 | 48.4 | 43.47 | 58.96 | 59.75 | 83.71 | 76.53 | 60.53 | 62.13 | 72.46 | 72.89 | 57.28 | 60.11 | 65.76 | 63.07 | 73.1 | 49.43 | 44.56 | 36.19 | 70.6 |
| Other Current Assets | 6.64M | 5.63M | 6.33M | 4.72M | 681K | 4.5M | 3.53M | 1.41M | 882K | 1.02M | 2.44M | 2.2M | 1.12M | 3.5M | 2.47M | 2.04M | 1.25M | 1.48M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 650.54K |
| Total Non-Current Assets | 37.63M | 69.83M | 76.24M | 39.57M | 25.32M | 26.31M | 26.3M | 28M | 29.6M | 31.02M | 22.65M | 2.45M | 4.17M | 2.99M | 3.46M | 16.68M | 17.67M | 20.34M | 28.23M | 3.25M | 2.67M | 2.25M | 2.66M | 2.64M | 1.17M | 3.28M | 3.42M |
| Property, Plant & Equipment | 26.84M | 29.82M | 28.09M | 26.18M | 24.46M | 25.45M | 25.45M | 27.14M | 28.74M | 30.16M | 20.93M | 1.57M | 1.31M | 2.13M | 2.6M | 3.43M | 4.43M | 5.06M | 1.9M | 1.99M | 1.5M | 1.29M | 1.69M | 1.5M | 1.12M | 3.19M | 3.31M |
| Fixed Asset Turnover | 6.67x | 7.61x | 9.76x | 9.80x | 11.18x | 11.93x | 11.17x | 10.44x | 9.53x | 8.26x | 11.21x | 146.20x | 178.16x | 106.86x | 91.74x | 67.48x | 53.80x | 43.38x | 98.95x | 81.51x | 91.87x | 84.24x | 55.67x | 36.72x | 28.59x | 3.14x | 4.44x |
| Goodwill | 0 | 26.66M | 26.66M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 10.79M | 13.35M | 11.2M | 5.86M | 860K | 860K | 860K | 860K | 860K | 860K | 860K | 860K | 860K | 860K | 860K | 860K | 850K | 850K | 365K | 365K | 365K | 365K | 365K | 365K | 0 | 0 | 0 |
| Long-Term Investments | 5.3M | 0 | 5.3M | 5M | 24.27M | 25.55M | 25.52M | 0 | 0 | 0 | -863K | -840K | -1.06M | 0 | 0 | 12.39M | 12.39M | 14.43M | 25M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | -5.3M | 0 | 4.99M | -5M | -25.32M | -26.31M | -26.3M | -28M | 0 | 0 | 863K | 840K | 2M | -982K | -1.23M | -1M | -1.25M | -724.56K | -260K | 0 | 14.17K | 14.17K | 21.82K | 200.16K | 50.16K | 94.23K | 116.91K |
| Total Assets | 81.19M | 148.7M | 169.88M | 170M | 176.32M | 187.5M | 155.32M | 154.43M | 134.84M | 112.81M | 90.28M | 82.85M | 78.38M | 73.18M | 91.06M | 106.29M | 104.17M | 81.96M | 73.45M | 61.22M | 42.62M | 28.12M | 18.48M | 9.03M | 4.65M | 4.5M | 6.33M |
| Asset Turnover | 2.20x | 1.53x | 1.61x | 1.51x | 1.55x | 1.62x | 1.83x | 1.84x | 2.03x | 2.21x | 2.60x | 2.77x | 2.98x | 3.11x | 2.62x | 2.18x | 2.29x | 2.68x | 2.56x | 2.65x | 3.23x | 3.85x | 5.09x | 6.09x | 6.88x | 2.22x | 2.32x |
| Asset Growth % | -45.4% | -12.47% | -0.07% | -3.58% | -5.96% | 20.71% | 0.58% | 14.53% | 19.53% | 24.96% | 8.96% | 5.71% | 7.1% | -19.64% | -14.32% | 2.03% | 27.09% | 11.58% | 19.99% | 43.62% | 51.58% | 52.16% | 104.76% | 93.93% | 3.32% | -28.79% | - |
| Total Current Liabilities | 52.03M | 62.77M | 72.16M | 57.51M | 33.2M | 44.94M | 24.34M | 18.63M | 18.11M | 18.36M | 7.08M | 7.42M | 8.09M | 9M | 9.39M | 8.96M | 7.09M | 6.99M | 6.42M | 7.35M | 4.98M | 3.9M | 4.49M | 3.36M | 2.79M | 3.7M | 2.5M |
| Accounts Payable | 20.91M | 23.56M | 37.02M | 25.21M | 27.5M | 39.55M | 19.66M | 16.27M | 15.27M | 15.22M | 5M | 5.15M | 5.77M | 6.45M | 6.62M | 6.45M | 4.78M | 4.82M | 4.36M | 5.86M | 3.05M | 2.72M | 3.27M | 2.57M | 2.72M | 1.54M | 1.28M |
| Days Payables Outstanding | 59.24 | 54.49 | 68.81 | 49.51 | 50.67 | 65.83 | 35.37 | 31.58 | 31.68 | 32.71 | 11.53 | 12.28 | 13.52 | 15.63 | 15.28 | 15.95 | 11.91 | 13.11 | 13.94 | 21.9 | 13.39 | 15.37 | 21.4 | 29.77 | 52.64 | 88.4 | 51.66 |
| Short-Term Debt | 0 | 461K | 459K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 68.44K | 68.44K | 68.44K | 1.91M | 1.03M |
| Deferred Revenue (Current) | 689K | 2.08M | 2.6M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 722.35K | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 29.93M | 36.66M | 30.54M | 30.74M | 4.56M | 1.83M | 1.64M | 613K | 431K | 1.06M | 315K | 409K | 1.57M | 1.48M | 1.7M | 1.53M | 368K | -65 | 0 | 999.84K | 802.51K | 491.19K | 422.44K | 170.75K | 0 | 250.05K | 195.05K |
| Current Ratio | 0.84x | 1.26x | 1.30x | 2.27x | 4.55x | 3.59x | 5.30x | 6.79x | 5.81x | 4.46x | 9.55x | 10.84x | 9.17x | 7.80x | 9.33x | 10.00x | 12.20x | 8.81x | 7.04x | 7.88x | 8.02x | 6.63x | 3.53x | 1.90x | 1.25x | 0.33x | 1.16x |
| Quick Ratio | 0.58x | 1.00x | 0.90x | 1.94x | 3.57x | 2.82x | 4.57x | 5.64x | 4.52x | 3.35x | 5.93x | 7.46x | 4.75x | 4.29x | 6.54x | 7.19x | 8.10x | 4.98x | 4.25x | 5.69x | 5.01x | 3.76x | 1.04x | 0.63x | 0.42x | 0.16x | 0.46x |
| Cash Conversion Cycle | -16.79 | -13.29 | -11.37 | -9.67 | 11.68 | -5.43 | 1.75 | 13.16 | 19.78 | 13.41 | 50.11 | 50.54 | 72.95 | 63.21 | 47.66 | 49.31 | 63.76 | 64.57 | 46.39 | 41.29 | 55.44 | 53.75 | 56.1 | 23.99 | -4.76 | -46.28 | 23.61 |
| Total Non-Current Liabilities | 217K | 798K | 995K | 2.53M | 936K | 1.28M | 970K | 1.12M | 996K | 1.09M | 5M | 5.15M | 65K | 168K | 492K | 321K | 225K | 4.82M | 4.36M | 5.86M | 3.05M | 2.72M | 3.34M | 68.44K | 278.1K | 49.45K | 2.19M |
| Long-Term Debt | 0 | 535K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 68.44K | 278.1K | 0 | 1.81M |
| Capital Lease Obligations | 42K | 0 | 995K | 995K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 49.45K | 0 |
| Deferred Tax Liabilities | 175K | 263K | 0 | 2.53M | 936K | 1.28M | 970K | 1.12M | 996K | 1.09M | 5K | 0 | 65K | 168K | 492K | 321K | 225K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | -995K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 383.4K |
| Total Liabilities | 52.25M | 63.57M | 73.15M | 60.04M | 34.13M | 46.22M | 25.31M | 19.75M | 19.11M | 19.44M | 7.08M | 7.42M | 8.16M | 9.16M | 9.88M | 9.28M | 7.31M | 6.99M | 6.42M | 7.35M | 4.98M | 3.9M | 4.49M | 3.43M | 3.07M | 3.75M | 4.7M |
| Total Debt | 535K | 996K | 1.45M | 995K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 68.44K | 136.88K | 346.54K | 1.96M | 2.83M |
| Net Debt | -20.88M | -53.72M | -53.84M | -103.09M | -111.08M | -118.72M | -103.76M | -100.53M | -77.94M | -58.73M | -37.64M | -35.61M | -18.3M | -18.16M | -46.8M | -49.66M | -53.14M | -30.13M | -20.27M | -316.47K | -23.22M | -12.68M | -3.21M | -847.28K | -390.74K | 1.55M | 2.52M |
| Debt / Equity | 0.02x | 0.01x | 0.02x | 0.01x | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.00x | 0.02x | 0.22x | 2.58x | 1.74x |
| Debt / EBITDA | - | 0.18x | 15.47x | 0.10x | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.01x | 0.04x | 0.35x | - | - |
| Net Debt / EBITDA | - | -9.75x | -572.79x | -10.21x | -3.90x | -3.60x | -3.12x | -2.08x | -1.44x | -1.51x | -1.14x | -1.26x | -0.63x | -0.65x | -1.71x | -1.44x | -1.27x | -0.86x | -0.71x | -0.01x | -1.24x | -0.97x | -0.33x | -0.22x | -0.40x | - | - |
| Interest Coverage | - | - | - | - | - | 25.23x | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1339.10x | - | -14.07x | -110.48x |
| Total Equity | 28.94M | 85.13M | 96.73M | 109.97M | 142.19M | 141.28M | 130.01M | 134.68M | 115.73M | 93.37M | 83.19M | 75.44M | 70.22M | 64.01M | 81.18M | 97M | 96.86M | 74.97M | 67.03M | 53.86M | 37.64M | 24.22M | 13.99M | 5.59M | 1.58M | 757.29K | 1.63M |
| Equity Growth % | -66.01% | -11.99% | -12.04% | -22.66% | 0.64% | 8.67% | -3.47% | 16.37% | 23.95% | 12.23% | 10.29% | 7.43% | 9.69% | -21.15% | -16.31% | 0.15% | 29.2% | 11.84% | 24.45% | 43.1% | 55.43% | 73.05% | 150.23% | 253.36% | 109% | -53.56% | - |
| Book Value per Share | 1.38 | 4.13 | 4.74 | 5.41 | 6.98 | 7.02 | 6.48 | 6.57 | 5.66 | 4.58 | 4.11 | 3.75 | 3.50 | 3.19 | 3.92 | 4.28 | 4.26 | 3.19 | 2.76 | 2.22 | 1.55 | 1.02 | 0.59 | 0.27 | 0.08 | 0.08 | 0.26 |
| Total Shareholders' Equity | 28.94M | 85.13M | 96.73M | 109.97M | 142.19M | 141.28M | 130.01M | 134.68M | 115.73M | 93.37M | 83.19M | 75.44M | 70.22M | 64.01M | 81.18M | 97M | 96.86M | 74.97M | 67.03M | 53.86M | 37.64M | 24.22M | 13.99M | 5.59M | 1.58M | 757.29K | 1.63M |
| Common Stock | 21K | 21K | 21K | 21K | 21K | 20K | 20K | 21K | 21K | 21K | 20K | 20K | 20K | 20K | 20K | 22K | 23K | 22.69K | 23.73K | 24.31K | 23.97K | 23.46K | 21.86K | 18.46K | 16.36K | 16.36K | 6.37K |
| Retained Earnings | 9.26M | 66.54M | 71.56M | 91.66M | 130.5M | 134.14M | 126.18M | 122.17M | 106.32M | 86.53M | 78.3M | 72.34M | 68.65M | 63.99M | 81.11M | 97.11M | 94.31M | 75.16M | 58.64M | 38.62M | 24.17M | 12.11M | 4.1M | -1.71M | -4.97M | -5.8M | -2.97M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -34.28K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -6.17M | -4.05M | -8.4M | -54K | -37K | -2K | 44K | -141K | -108K | -219.75K | -2.92M | -2.33M | -1.8M | -1.96M | -1.39M | -840K | -831.86K | -771.04K | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Liquidity and capital erosion
As reported in recent financial filings, PETS has seen its total assets decline from $175.1M in 2024Q4 to $81.2M in 2026Q4, a trend that underscores the rapid erosion of the company's balance sheet strength as it struggles to maintain its competitive position in the pet pharmacy market.
The consistent reduction in total assets suggests that the company is liquidating or consuming its resource base to fund ongoing operations rather than reinvesting for growth. This trajectory indicates a business model in retreat, where the shrinking asset base may eventually limit the firm's ability to support its core pharmacy fulfillment infrastructure.
Based on the company's reported figures, the current ratio has deteriorated from 1.30 in 2024Q4 to 0.84 in 2026Q4, signaling that the firm's ability to cover short-term obligations is increasingly compromised as cash reserves dwindle to $21.4M against a backdrop of persistent operational losses.
The decline in the current ratio below parity suggests that the company is becoming reliant on external liquidity or further asset liquidation to meet its immediate liabilities. Investors should monitor this trend closely, as the current cash runway appears insufficient to support the business if the current burn rate persists without a structural turnaround.
According to the provided balance sheet data, retained earnings have plummeted from $71.6M in 2024Q4 to $9.3M in 2026Q4, reflecting a significant destruction of shareholder equity as the company continues to absorb substantial net losses while failing to generate sustainable internal capital.
The rapid depletion of retained earnings indicates that the company's historical profitability has been entirely reversed, forcing a reliance on existing equity to absorb operating deficits. This trend warrants further investigation into whether the current capital structure can remain viable without significant dilution or a fundamental shift in the cost-to-revenue ratio.
As indicated by the financial statements, the company's goodwill balance dropped from $26.7M in 2025Q4 to $10.8M in 2026Q4, suggesting that management has begun to recognize the diminished value of past acquisitions in the face of the current operational downturn.
The significant write-down of goodwill implies that previous strategic investments have failed to deliver the expected synergies or market share gains. This development suggests that the remaining intangible assets may still be subject to further impairment if the core pharmacy business continues to lose active customers to larger, more integrated e-commerce competitors.
Quick answers to the most common questions about buying PETS stock.
As of 2026, PetMed Express, Inc. (PETS) had total assets of $81.2M including $43.6M in current assets.
PetMed Express, Inc. (PETS) carries total debt of $0.5M, offset by $21.4M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
PetMed Express, Inc. (PETS) has total shareholders' equity (book value) of $28.9M ($1.38 book value per share). Book value represents the net worth of the company belonging to common stock holders.
PetMed Express, Inc. (PETS) reported a current ratio of 0.84x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.